CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule, Biologics), Therapeutic Area (Oncology, Neurology, Infectious), End User (Pharma, Biotech, Academic) & Region - Global Forecasts to 2028
... global Drug discovery services market is projected to reach USD 41.3 billion by 2028 from USD 20.6 billion in 2023, at a CAGR of 14.9% during the forecast period of 2023 to 2028. Growing R&D ... Read More
-
Global Gene Therapy Market Size study & Forecast, by Vector [Viral VectorsNon-viral VectorsBy Delivery Method (In Vivo, Ex Vivo) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Others), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029
... (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Receptors, Others), and Regional Analysis, 2022-2029 Global Gene Therapy Market is valued at approximately USD 6.2 billion in 2021 and is anticipated to grow with a healthy growth rate ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Yttrium-90 (Y-90), Fluorine-18 (18F), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... (18F), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, ... Read More
-
Global Japanese Encephalitis Vaccines Market Growth 2023-2029
... form of the disease is encephalitis, and less severe forms such as aseptic meningitis or simple fever syndrome with headache are also frequent. The mortality rate of Japanese encephalitis is high, and sequelae are very ... Read More
-
Neurofeedback Market, by Product (Amplifiers, Electrodes or Sensors, and Computer Software), by System (Frequency/Power Neurofeedback System, Slow Cortical Potential Neurofeedback (SCP-NF) System, Low-Energy Neurofeedback System (LENS), Hemoencephalographic (HEG) Neurofeedback System, Live Z-Score Neurofeedback System, Low-Resolution Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Electromagnetic Tomography (LORE-TA), and Functional Magnetic Resonance Imaging (fMRI)), by Application (Attention Deficit Hyperactivity Disorder (ADHD), Anxiety, Depression, Epilepsy, Insomnia, Drug Addiction, Schizophrenia, and Others), by End User (Hospitals, Ambulatory Surgical Center, Clinics, and Others), ... Read More
-
Global Benzodiazepines Market Growth (Status and Outlook) 2023-2029
... region and market sector of projected Benzodiazepines sales for 2023 through 2029. With Benzodiazepines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world ... Read More
-
Global JE (Japanese Encephalitis) Vaccine Market Report and Forecast 2023-2028
... in 2022. Aided by the increase in the prevalence and incidence of Japanese encephalitis disease, the market is projected to further grow at a CAGR of 6.8% between 2023 and 2028 to reach a value ... Read More
-
Global Gene Therapy for CNS Disorders Market Growth (Status and Outlook) 2023-2029
... be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them ... Read More
-
Sleep Tech Devices Market Analysis And Forecast To 2032: By Product (Wearables, Non-wearables), Application (Insomnia, Obstructive Sleep Apnea, Narcolepsy) and Distribution Channel (Specialty Clinics, Direct-to-Consumer, Hospitals), And Region
... valued at USD 16.4 Billion in 2022 and it is anticipated to grow up to USD 95.8 Billion by 2032, at a CAGR of 19.3% during the forecast period. Sleep tech devices are designed for ... Read More
-
U.S. Memory Care Market Size, Share & Trends Analysis Report By Services (Memory Exercise & Activity, Daily Reminder, Personal Assistance Safety), By End-use (Long Term Care Centers, Home Care Settings), And Segment Forecasts, 2023 - 2030
... 2030 U.S. Memory Care Market Growth & Trends The U.S. memory care market size is anticipated to account for USD 8.61 billion by 2030, registering a CAGR of 5.1% from 2023 to 2030, according to ... Read More
-
Global Recurrent Glioblastoma Multiforme Treatment Market Growth (Status and Outlook) 2023-2029
... Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Recurrent Glioblastoma Multiforme Treatment sales for 2023 through 2029. With Recurrent Glioblastoma Multiforme Treatment sales broken down by region, market ... Read More
-
Personalized Medicine Market By Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics), By Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, Others), By End User (Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... The personalized medicine market valued for $300.00 billion in 2021 and is estimated to reach $869.48 billion by 2031, exhibiting a CAGR of 11.2% from 2022 to 2031. Personalized medicines are the medical treatment regime ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030
... Market Growth & Trends The global immunoassay for neurological biomarkers market size is expected to reach USD 2.24 billion by 2030, registering a CAGR of 17.8% from 2023 to 2030, according to a new report ... Read More
-
Hyper Personalized Medicine Market By Product (Hyper Personalized Medicine Diagnostics, Hyper Personalized Medicine Therapeutics, Hyper Personalized Medical Care, Hyper Personalized Nutrition and Wellness), By Application (Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology), By End User (Hospitals, Diagnostic Centers, Research and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... End User (Hospitals, Diagnostic Centers, Research and Academic Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global hyper personalized medicine market is anticipated to reach $5.9 trillion by 2031, growing from $2.1 trillion ... Read More
-
Neurodegenerative Drugs Market By Drug Class (Dopamine agonist , Decarboxylase inhibitors , Cholinesterase Inhibitors , Immunomodulators, Others ), By Indication (Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis , Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031 The neurodegenerative drugs market valued for $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, exhibiting a CAGR of ... Read More
-
Brain Mapping Instruments Market By Product Type (Computed Tomography, Positron Emission Tomography (PET), Electroencephalography (EEG), Near-Infrared Spectroscopy (NIRS), Magnetic Resonance Imaging (MRI), Others), By End User (Hospitals, Ambulatory Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Forecast, 2021-2031 The brain mapping instruments market was valued at $2.1 billion in 2021, and is estimated to reach $3.7 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031. The brain ... Read More
-
Global Acute Migraine Drugs Market - Analysis By Drug Type (Ergot Alkaloids, Analgesics, Triptans, Others), Route of Administration, Availability, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)
... global Acute Migraine Drugs market was worth USD 8.40 billion in 2021 and is anticipated to expand at a CAGR of 7.82% between 2023 and 2028. The rising prevalence of migraine among the working population, ... Read More
-
Global Anorexiants Market Growth (Status and Outlook) 2023-2029
... “Anorexiants Industry Forecast” looks at past sales and reviews total world Anorexiants sales in 2022, providing a comprehensive analysis by region and market sector of projected Anorexiants sales for 2023 through 2029. With Anorexiants sales ... Read More
-
Medical Robots Market Size, By Product (Surgical Robots, Telemedicine Robots, Rehabilitation Robots, Non-invasive Radiosurgery Robots, Pharmacy and Hospital Automation Robots), By Application (Neurology Applications, Cardiology Applications, Orthopedic Applications, Laparoscopic Applications, Physical Rehabilitation, Pharmacy Applications), By End-use (Hospitals, Rehabilitation Centers, Ambulatory Surgical Centers (ASCs)), Industry Analysis Report, Country Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
... End-use (Hospitals, Rehabilitation Centers, Ambulatory Surgical Centers (ASCs)), Industry Analysis Report, Country Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 Global Medical Robots Market is estimated to showcase positive trajectory through 2032 ... Read More
-
Cognitive Impairment Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Cognitive Impairment Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Japanese Encephalitis Pipeline Report, 2023- Planned Drugs by Phase, Mechanism of Action, Route of Administration, Type of Molecule, Market Trends, Developments, and Companies
... clinical stage pipeline candidates under development as of H1- 2023. For each of the Japanese Encephalitis pipeline candidate, details of leading companies, phase of development, mechanism of action, route of administration, molecule type, and other ... Read More
-
Global Diagnostic Imaging Market Size study, by Product (MRI Systems, Ultrasound Imaging Systems, CT Scanners, Others), by Application (Cardiology, Oncology, Neurology, Others), by End-User (Hospital, Diagnostic Center) and Regional Forecasts 2022-2029
... is valued approximately at USD 26.6 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.7 % over the forecast period 2022-2029. Diagnostic Imaging is a technique which ... Read More
-
RNAi Therapeutics Market Analysis And Forecast To 2032: Type (Small Interfering RNAS, Microrna), Application (Genetic Disorder, Oncology, Neurodegenerative Disorder, Cardiovascular Disorder, Respiratory Disorder, Neurodegenerative Disorders, Renal Disease, Other), Route of Administration (Intradermal Injections, Pulmonary Delivery, Intravenous Injections, Intraperitoneal Injections, Topical Delivery, Others), And Region
... A brand-new class of drugs based on ribonucleic acid is known as RNA therapies (RNA). Target mRNA molecules are neutralized during the biological process known as RNA interference, and RNA molecules are then shown to ... Read More
-
Brain Health Supplements Market Size, Share & Trends Analysis Report By Product (Natural Molecules, Vitamins & Minerals), By Application (Memory Enhancement, Attention & Focus), By Region, And Segment Forecasts, 2023 - 2030
... Market Growth & Trends The global brain health supplements market size is expected to reach USD 23.41 billion by 2030, expanding at 13.3% CAGR from 2023 to 2030, according to a new report by Grand ... Read More
-
Vocal Biomarkers Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Frequency, Amplitude, Error Rate, Vocal Rise/Fall Time, Phonation Time, Voice Tremor, Pitch); By Indications (Depression, Attention Deficit, Disruptive Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America)
... Behavior Disorders); By Neurological Disorders (Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, Respiratory & Cardiovascular Disorders, Traumatic Brain Injury); By End User (Hospitals & Clinics, Academic & Research); By Region (North America, Europe, Asia Pacific, Middle ... Read More
Research Assistance
